Platelet components associated with adverse reactions: Predictive value of mitochondrial DNA relative to biological response modifiers

Transfusion

Volumn 56, Issue 2, 2016, Pages 497-504

  Cognasse, Fabrice ^a,b   Aloui, Chaker ^b   Anh Nguyen, Kim ^b   Hamzeh Cognasse, Hind ^b   Fagan, Jocelyne ^a   Arthaud, Charles Antoine ^a   Eyraud, Marie Ange ^a   Sebban, Marc ^c   Fromont, Elisa ^c   Pozzetto, Bruno ^b   Laradi, Sandrine ^a,b   Garraud, Olivier ^b,d  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

^b UNIVERSITÉ DE LYON   (France)

^c CNRS   (France)

^d INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL RESPONSE MODIFIER; CD40 LIGAND; CXCL9 CHEMOKINE; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 23; INTERLEUKIN 33; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MITOCHONDRIAL DNA; RANTES; SECONDARY LYMPHOID TISSUE CHEMOKINE; THYMIC STROMAL LYMPHOPOIETIN;

ADVERSE OUTCOME; ALLERGY; AREA UNDER THE CURVE; ARTICLE; BACTERIAL INFECTION; BLOOD COMPONENT; BLOOD STORAGE; BLOOD TRANSFUSION REACTION; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; INFLAMMATION; MATHEMATICAL MODEL; PATIENT RISK; PLATELET COMPONENT; PROTEIN SECRETION; RISK ASSESSMENT; RISK FACTOR; THROMBOCYTE TRANSFUSION; THROMBOCYTOPHERESIS; TRANSFUSION RELATED ACUTE LUNG INJURY; ADVERSE EFFECTS; CLINICAL TRIAL; FEMALE; MALE; METABOLISM; MULTICENTER STUDY; THROMBOCYTE; TIME FACTOR;

BLOOD PLATELETS; BLOOD PRESERVATION; CD40 LIGAND; DNA, MITOCHONDRIAL; FEMALE; HUMANS; INTERLEUKIN-13; MALE; PLATELET TRANSFUSION; TIME FACTORS;

EID: 84958906914     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13373     Document Type: Article

References (28)

1. ANSM. Onzième rapport des données nationales d'hémovigilance. Saint-Denis Cedex: Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM); 2013. pp 1-91.
2. Tung JP, Fraser JF, Nataatmadja M, et al., Age of blood and recipient factors determine the severity of transfusion-related acute lung injury (TRALI). Crit Care 2012; 16: R19.
3. Heddle NM., Pathophysiology of febrile nonhemolytic transfusion reactions. Curr Opin Hematol 1999; 6: 420-6.
4. Sayah DM, Looney MR, Toy P., Transfusion reactions: newer concepts on the pathophysiology, incidence, treatment, and prevention of transfusion-related acute lung injury. Crit Care Clin 2012; 28: 363-72.
5. Cognasse F, Osselaer JC, Payrat JM, et al., Release of immune modulation factors from platelet concentrates during storage after photochemical pathogen inactivation treatment. Transfusion 2008; 48: 809-13.
6. Cognasse F, Payrat JM, Corash L, et al., Platelet components associated with acute transfusion reactions: the role of platelet-derived soluble CD40 ligand. Blood 2008; 112: 4779-80.
7. Park JW, Piknova B, Kurtz J, et al., Effect of storage on levels of nitric oxide metabolites in platelet preparations. Transfusion 2013; 53: 637-44.
8. Sandgren P, Meinke S, Eckert E, et al., Random aggregates in newly produced platelet units are associated with platelet activation and release of the immunomodulatory factors sCD40L and RANTES. Transfusion 2014; 54: 602-12.
9. West AP, Khoury-Hanold W, Staron M, et al., Mitochondrial DNA stress primes the antiviral innate immune response. Nature 2015; 520: 553-7.
10. Boudreau LH, Duchez AC, Cloutier N, et al., Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation. Blood 2014; 124: 2173-83.
11. Blumberg N, Gettings KF, Turner C, et al., An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions. Transfusion 2006; 46: 1813-21.
12. Blumberg N, Spinelli SL, Francis CW, et al., The platelet as an immune cell-CD40 ligand and transfusion immunomodulation. Immunol Res 2009; 45: 251-60.
13. Phipps RP, Kaufman J, Blumberg N., Platelet derived CD154 (CD40 ligand) and febrile responses to transfusion. Lancet 2001; 357: 2023-4.
14. Khan SY, Kelher MR, Heal JM, et al., Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 2006; 108: 2455-62.
15. Refaai MA, Phipps RP, Spinelli SL, et al., Platelet transfusions: impact on hemostasis, thrombosis, inflammation and clinical outcomes. Thromb Res 2011; 127: 287-91.
16. Reesink HW, Lee J, Keller A, et al., Measures to prevent transfusion-related acute lung injury (TRALI). Vox Sang 2012; 103: 231-59.
17. Silliman CC, McLaughlin NJ., Transfusion-related acute lung injury. Blood Rev 2006; 20: 139-59.
18. Nguyen KA, Hamzeh-Cognasse H, Sebban M, et al., A computerized prediction model of hazardous inflammatory platelet transfusion outcomes. PLoS One 2014; 9: e97082.
19. Hamzeh-Cognasse H, Damien P, Nguyen KA, et al., Immune-reactive soluble OX40 ligand, soluble CD40 ligand, and interleukin-27 are simultaneously oversecreted in platelet components associated with acute transfusion reactions. Transfusion 2014; 54: 613-25.
20. Heddle NM, Blajchman MA, Meyer RM, et al., A randomized controlled trial comparing the frequency of acute reactions to plasma-removed platelets and prestorage WBC-reduced platelets. Transfusion 2002; 42: 556-66.
21. Li H, Liu D, Lu J, et al., Physiology and pathophysiology of mitochondrial DNA. Adv Exp Med Biol 2012; 942: 39-51.
22. ISBT International Society of Blood Transfusion, Working Party on Haemovigilance Network. Proposed standard definitions for surveillance of non infectious adverse transfusion reactions. New York: Wiley; 2011.
23. Tinegate H, Birchall J, Gray A, et al., Guideline on the investigation and management of acute transfusion reactions. Prepared by the BCSH Blood Transfusion Task Force. Br J Haematol 2012; 159: 143-53.
24. Cognasse F, Boussoulade F, Chavarin P, et al., Release of potential immunomodulatory factors during platelet storage. Transfusion 2006; 46: 1184-9.
25. Blumberg N, Phipps RP, Kaufman J, et al., The causes and treatment of reactions to platelet transfusions. Transfusion 2003; 43: 291 -2.
26. Sahler J, Spinelli S, Phipps R, et al., CD40 ligand (CD154) involvement in platelet transfusion reactions. Transfus Clin Biol 2012; 19: 98-103.
27. Hei DJ, Grass J, Lin L, et al., Elimination of cytokine production in stored platelet concentrate aliquots by photochemical treatment with psoralen plus ultraviolet A light. Transfusion 1999; 39: 239-48.
28. Morrell CN., Immunomodulatory mediators in platelet transfusion reactions. Hematology Am Soc Hematol Educ Program 2011; 2011: 470-4.